Prostate Cancer Awareness Month

Find out more
Blog | Prostate Cancer Awareness Month

Understanding the importance of prostate cancer awareness

Prostate Cancer Awareness Month is a time to highlight the significance of early detection and encourage men to prioritise their health. Prostate cancer is the most common cancer in men in the UK, with one in eight men diagnosed in their lifetime. Raising awareness can help men take control of their health and improve early diagnosis rates.

Prostate cancer often develops slowly, meaning many men may not experience symptoms until the disease has progressed. However, early detection significantly increases the chances of successful treatment.

  • Early detection means survival rates of 98%, compared to just 30% when diagnosed at an advanced stage.
  • Over 52,000 men are diagnosed with prostate cancer every year in the UK.
  • More than 12,000 men lose their lives to the disease annually – one every 45 minutes.
  • Men over 50, black men, and those with a family history of prostate cancer are at a higher risk.

Despite these statistics, many men avoid screenings due to fear, misinformation, or lack of symptoms.

Why some men delay prostate cancer screening

Lack of Symptoms 
Unlike other cancers, prostate cancer can remain symptomless in its early stages.

Many men assume that no symptoms mean no risk, but routine testing is key to early diagnosis. 

Fear of diagnosis 
A cancer diagnosis can feel overwhelming, leading some men to avoid testing altogether. However, early detection means more treatment options and better outcomes.

Embarrassment or stigma 
Discomfort around discussing prostate health is common. However, breaking the silence and normalising regular screening can help save lives.

Busy lifestyles 
Between work and personal responsibilities, it’s easy for health to take a backseat. However, screening is quick, non-invasive, and could be life-saving.

How Check4Cancer can help

At Check4Cancer, we offer simple, clinically validated screening options to help men take charge of their prostate health.

  • Fast, reliable screening tests with expert guidance
  • Clinically governed, evidence-based solutions designed for early detection.
  • Accessible private testing options, helping to overcome long NHS wait times.

Whether for yourself or your employees, proactive screening can make all the difference.

Take Action Today

This Prostate Cancer Awareness Month, encourage the people in your life to support men's health and early detection.

Because it’s always better to know...

richard hindley avatar image

Professor Richard Hindley

Clinical Advisor for Prostate Cancer

Consultant Urologist at Hampshire Hospitals. Visiting Professor at the department of Health & Wellbeing at the University of Winchester Richard Hindley is a Consultant Urologist at Hampshire Hospitals and was appointed in 2014. In 2017 he was awarded a visiting Professor position working with the Department of Health and Wellbeing at the University of Winchester. This was in recognition of his growing prostate research portfolio which includes collaborating with other units including UCLH and the University of Oxford. He was privileged to be involved with the PROMIS and PRECISION trials, which have changed forever the diagnostic pathway for men with suspected prostate cancer. He has publications in both the Lancet at the NEJM. His interests relate not only to prostate cancer diagnostics but also focal therapy as a treatment option for men with intermediate risk prostate cancer, as well as minimally invasive treatments for benign prostatic obstruction and men’s health issues in general.

Find out more

Knowledge and support

Go to all articles
Leading the Way in Cancer Risk Stratification and Screening

Leading the Way in Cancer Risk Stratification and Screening

From advanced screening techniques to innovative risk stratification tools, here's how we are actively shaping the future of cancer care.

Read more
Professor Andrew Beggs Honoured with the Josiah Mason Award for Academic Achievement

Professor Andrew Beggs Honoured with the Josiah Mason Award for Academic Achievement

Check4Cancer is proud to congratulate Professor Andrew Beggs, Clinical Advisor to Check4Cancer, on receiving the prestigious Josiah Mason Award for...

Read more
Dr Haider Raza Joins Check4Cancer to Advance AI-Powered Skin Cancer Detection

Dr Haider Raza Joins Check4Cancer to Advance AI-Powered Skin Cancer Detection

Check4Cancer is thrilled to announce the appointment of Dr Haider Raza to its Clinical Advisory Board.

Read more